Global Preterm Birth and PROM Testing Market - Snapshot

Premature rupture of membranes (PROM) is one of the leading causes of preterm births. Increase in number of preterm births due to rise in average age of women being pregnant and various health concerns such as diabetes and high blood pressure among women drive the global preterm birth and prom testing market. Additionally, increase in demand for point-of-care testing devices and rise in demand for cost effective diagnostic tests are the key factors propelling the market. However, lack of awareness about new technologies for diagnosis of preterm births and use of alternative diagnostic options such as ultrasound, transvaginal scan, uterine monitoring, and lab tests restrain the global market.

Based on test type, the global preterm birth and PROM testing market has been bifurcated into preterm birth tests and PROM tests. The preterm birth tests segment has been classified into pelvic exam, ultrasound, uterine monitoring, and biomarkers. The PROM tests segment has been categorized into nitrazine test, ferning test, pooling, ultrasound, fetal fibronectin test, biomarkers, and others. Increase in the number of preterm births, high incidence of preterm births, rise in the number of specialty clinics, and easy detection of preterm birth through PROM tests are expected to augment the segment. In terms of revenue, the preterm birth tests segment dominated the global preterm birth and PROM testing market. However, availability of other tests in the market is likely to hamper the growth of the segment.

preterm-birth-prom-testing-market.jpg

In terms of end-user, the global preterm birth and PROM testing market has been divided into hospitals, diagnostic laboratories, and others. Increase in awareness about specialty treatments is a key driver of the diagnostic laboratories segment. Additionally, surge in demand for preterm diagnostic services and rise in the number of diagnostic procedures such as ultrasound and pelvic examinations for pregnant women are anticipated to propel the segment. The others segment is likely to witness strong growth during the forecast period due to shift of treatment toward nursing homes and specialized clinics.

In terms of region, the global preterm birth and PROM testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presence of key players, increase in demand for preterm birth testing, and rise in preterm birth rates are factors boosting the growth of the market in North America. Technological advancements, rise in the number of approvals for preterm and PROM tests from the European Commission, and increase in demand for preterm birth diagnostic tests propel the preterm birth and PROM testing market in Europe. Focus on early diagnosis of women’s health problems, rise in government initiatives toward maternal health, and increase in the number of preterm births are the major factors driving the market in Asia Pacific. Growth of the market in Latin America is attributed to rapid adoption of new technologies, increase in use of point-of-care testing devices & tools, and rise in the number of players offering products in the market. Additionally, surge in awareness about product offerings for preterm birth and PROM testing is expected to augment the market in Latin America during the forecast period.

Major players operating in the global preterm birth and PROM testing market include QIAGEN, Hologic, Inc., Medix Biochemica, Biosynex, Abbott Laboratories, Clinical Innovations, LLC, Sera Prognostics, Inc., The Cooper Companies, Inc., NX Prenatal, Inc., and IQ Products. Focus on technological advancements in preterm birth and PROM testing is expected to drive the global market during the forecast period.

Global Preterm Birth and PROM Testing Market: Overview

This report analyzes the current and future scenario of the global preterm birth and PROM testing market. Increase in preterm births, rise in demand for point-of-care testing devices, surge in demand for cost-effective diagnostic tests are projected to drive the global preterm birth and PROM testing market during forecast period. Additionally, effective and early diagnosis and reduction in false positive tests are the factors driving demand for point-of-care testing devices for detection of preterm births.

The global preterm birth and PROM testing market report comprises an elaborate executive summary, which includes information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on test type, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global preterm birth and PROM testing market.

Global Preterm Birth and PROM Testing Market: Key Segments

Based on test type, the global preterm birth and PROM testing market has been bifurcated into preterm birth tests and PROM tests. The preterm birth tests segment has been classified into pelvic exam, ultrasound, uterine monitoring, and biomarkers. The PROM tests segment has been categorized into nitrazine test, ferning test, pooling, ultrasound, fetal fibronectin test, biomarker, and others. The most commonly used method for the determination of preterm birth is through the use of biomarkers. PROM tests such as ultrasound, biomarkers, and fetal fibronectin tests are widely conducted in hospitals and clinics to determine the occurrence of PROM. In terms of end-user, the market has been categorized into hospital, diagnostics laboratories, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Preterm Birth and PROM testing Market: Regional Outlook

In terms of region, the global preterm birth and PROM testing market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global preterm birth and PROM testing market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. These players include QIAGEN, Hologic, Inc., Medix Biochemica, Biosynex, Abbott Laboratories, Clinical Innovations, LLC, Sera Prognostics, Inc., The Cooper Companies, Inc., NX Prenatal, Inc., and IQ Products.

The global preterm birth and PROM testing market has been segmented as below:

  • Global Preterm Birth and PROM Testing Market, by Test Type
    • Preterm Birth Tests
      • Pelvic Exam
      • Ultrasound
      • Uterine Monitoring
      • Biomarkers
    • PROM Tests
      • Nitrazine Test
      • Ferning Test
      • Pooling
      • Ultrasound
      • Fetal Fibronectin Test
      • Biomarker Tests
      • Others
  • Global Preterm Birth and PROM Testing Market, by End-user
    • Hospitals
    • Diagnostics Laboratories
    • Others
  • Global Preterm Birth and PROM Testing Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Italy
      • France
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Israel
      • Rest of Middle East & Africa
.